Prostate Cancer - Results from #2280

Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration. August 24, 2023

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). August 24, 2023

Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. August 24, 2023

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging. August 24, 2023

FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence August 23, 2023

Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group August 23, 2023

Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. August 23, 2023

Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd? August 23, 2023

DIPPER trial protocol: A multi-centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002). August 23, 2023

A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer. August 23, 2023

Estimated Absolute Percentage of Biopsied Tissue Positive for Gleason Pattern 4 (eAPP4) in Low Dose Rate Prostate Brachytherapy: Evaluation of Prognostic Utility in a Large Cohort. August 23, 2023

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial August 22, 2023

Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study August 22, 2023

Peri Prostatic Adipose Tissue (PPAT) MRI Radiomics Derived Features Associated with Clinically Significant Prostate Cancer. August 22, 2023

Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT. August 22, 2023

Persistent organic pollutants promote aggressiveness in prostate cancer. August 22, 2023

Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy. August 22, 2023

Proton Therapy for the Management of Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center. August 22, 2023

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial August 21, 2023

Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer August 21, 2023

Page 115 of 1439